A Study to Evaluate the Effect of Deucravacitinib on Quality of Life in Participants With Plaque Psoriasis in a Community Setting
Clinical trial NCT05701995 · COMPLETED
Trial details
- NCT number
- NCT05701995
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-31
- Primary completion
- 2024-08-23
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.